A probe into counterfeit medicines in Uttar Pradesh has exposed an interstate drug manufacturing and supply racket, with investigators uncovering two unlicensed pharmaceutical units in Himachal Pradesh. The raids in Himachal’s Solan and Baddi led to the seizure of drug manufacturing machinery, raw materials, semi-finished products and finished medicines bearing the names of established pharmaceutical brands.The investigation, which began with the seizure of suspected fake medicines from a medical store in Varanasi, gradually led the Uttar Pradesh Food Safety and Drug Administration (UPFSDA) to the suppliers, storage facilities and manufacturing locations.
The department carried out the operation in coordination with the Uttar Pradesh Special Task Force (STF).The latest breakthrough came with the discovery of an unlicensed manufacturing unit at V.D. Pharma in Baddi's Jhundikalan area, following an earlier raid in Solan district.
The Himachal Pradesh drug control authorities and police are now taking further action.The operation was conducted under the supervision of the UPFSDA Commissioner as part of the Uttar Pradesh government's zero-tolerance policy towards the illegal drug trade. VARANASI MEDICAL STORE RAID SET INVESTIGATION IN MOTIONThe investigation began on October 30, 2026, when a UPFSDA team raided SP Medical Store in Varanasi.
The store was operating without a drug licence and was found selling Nurokind-LC tablets bearing the name of the pharmaceutical company Mankind.During questioning, the store owner, Sunil Kumar Patel, told investigators that he had purchased the medicines without bills from Ashok Kumar Verma, a salesman associated with Super Drug Agency in Lahartara. The team contacted Mankind for verification.
Following the company's complaint and a comparative examination of the products, the medicines were confirmed to be counterfeit. The team also seized other illegal medicines worth around Rs 5 lakh during the operation.The findings prompted investigators to trace the supply agency and identify the people involved in distributing the suspected fake medicines.STORAGE FACILITY EXPOSED, 17 TYPES OF MEDICINES SEIZEDActing on the information gathered during the first raid, a joint UPFSDA team questioned Ashok Verma and delivery agent Priyanshu Tiwari on November 2.Their questioning led investigators to the residence of Surendra Nath Mishra in Varanasi.
A room on the premises contained a large stock of 17 types of allopathic medicines stored without bills or a licence.Investigators noticed serious labelling and spelling errors on strips of Gudcef-Plus and Nurokind-LC, raising suspicions that the medicines were counterfeit. Eleven samples were collected for testing, while the remaining stock, estimated to be worth around Rs 2 lakh, was seized.The discovery shifted the focus of the investigation from retail outlets and distributors to the people storing and supplying the medicines in bulk.ZANGI APP LEADS INVESTIGATORS TO KEY SUPPLIERDuring questioning, Surendra Nath Mishra told investigators that he received the suspected counterfeit medicines from Abhishek Singh alias Ravi, a resident of Anpara in Sonbhadra district.He also disclosed that he communicated with Singh through the encrypted messaging application Zangi App.Following this lead, an FIR was registered at Rohania police station against four accused under relevant provisions of the Bharatiya Nyaya Sanhita (BNS), on the complaint of a drug inspector.Investigators also found that Abhishek Singh had earlier been named as the main accused in a major counterfeit medicine case registered at Varanasi's Sigra police station in 2023.
His arrest proved crucial in tracing the alleged manufacturing network.ACCUSED'S QUESTIONING LEADS TEAM TO HIMACHALDuring questioning, Abhishek Singh provided information about the locations where the suspected counterfeit medicines were being manufactured. The names of Saharanpur residents Haseen and Waseem, both sons of Salim and originally from Chilkhana, also emerged during the investigation.Investigators found that the two were getting medicines manufactured in the Solan region of Himachal Pradesh before supplying them to different markets.After corroborating the information with inputs from informers, a UPFSDA special investigation team, along with the Lucknow STF, conducted a raid on November 18 at a manufacturing unit in the Rajpura-Khera bypass area of Nalagarh tehsil in Solan district.The unit was found operating without a licence.
Investigators also recovered machinery used in manufacturing medicines and materials for replicating the packaging of established pharmaceutical brands.MACHINERY, PACKAGING MATERIAL FOR BRANDED MEDICINES RECOVEREDThe raid led to the recovery of materials linked to several pharmaceutical products, including Pan-D (Alkem), Pressiz-300, C-AZ, A-Cipex-625, Neruro-300, Clavam-625, Clav-625, Cef-200LB, Obefix LB-200, Alcemox-CV, Zedi-200-LB, V-Clav-625, Zerodol-SP and Shelcal-500 mg.The premises had machinery for manufacturing and packaging medicines, including blister-packing machines, Alu-Alu packing machines, capsule-filling machines and weighing equipment.Investigators also found printed foil, stereo-printing materials and other packaging equipment. The recovered material is being examined to establish how medicines bearing the names and packaging of established pharmaceutical brands were being manufactured and supplied.SECOND ILLEGAL UNIT FOUND IN BADDIFurther leads obtained during the Solan operation took investigators to V.D.
Pharma in Jhundikalan, Baddi.The team found another pharmaceutical manufacturing unit operating without a licence. Machinery and equipment used for manufacturing tablets, capsules and syrups were recovered from the premises.A substantial quantity of raw materials, semi-finished medicines and finished products was also seized.
These included materials associated with the manufacture of antibiotics, antacids and cough syrups.The scale of the machinery and material recovered indicated that the premises had an extensive arrangement for drug manufacturing. Further legal action in connection with the unit is being undertaken by the Himachal Pradesh drug control department.INVESTIGATION ALSO EXTENDS TO SAHARANPURThe investigation has now expanded to locations in Saharanpur linked to Haseen and Waseem.
Investigators have found leads relating to the alleged illegal manufacture, storage and sale of medicines at identified premises in the district.Legal action is being initiated at these locations, including the process of registering FIRs.The UPFSDA investigation has thus moved beyond the initial counterfeit medicine seizure in Varanasi to suspected manufacturing facilities, bulk storage locations and supply channels spread across multiple states. Investigators are continuing to examine the network and establish the extent of its operations.- Ends

